(Q30820751)

21 September 2017

Antibacterial and antiyeast compounds from marine-derived bacteria (English)

1 reference

(1S,2E,7R,10Z,12E,15R,16E,18Z,21S,23R,24R)-23,24-dihydroxy-7-methyl-15-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,25-dioxabicyclo[19.3.1]pentacosa-2,10,12,16,18-pentaen-9-one

21 September 2017

1 reference

1 reference

inferred from

reverse claim

author name string

Muhammad Abdul Mojid Mondol

series ordinal

1

1 reference

21 September 2017

Hee Jae Shin

series ordinal

2

1 reference

21 September 2017

language of work or name

1 reference

13 May 2014

1 reference

full work available at URL

21 September 2017

https://www.mdpi.com/1660-3397/12/5/2913/pdf?version=1424782956

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.3390/md12052913?email=unpaywall_01@example.com

published in

Marine Drugs

1 reference

21 September 2017

12

1 reference

21 September 2017

2913-2921

1 reference

21 September 2017

5

1 reference

Creative Commons Attribution 4.0 International

21 September 2017

start time

13 May 2014

1 reference

April 2022 Public Data File from Crossref

0 references

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.3390/md12052913?email=unpaywall_01@example.com

access restriction status

open access

1 reference

inferred from online access status

cites work

Diversity of secondary metabolites from marine Bacillus species: chemistry and biological activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

Macrolactin W, a new antibacterial macrolide from a marine Bacillus sp.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

Immense essence of excellence: marine microbial bioactive compounds

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

Microbial drug discovery: 80 years of progress

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

Drug development from marine natural products

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052323

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

21 June 2018

1 reference

https://api.crossref.org/works/10.3390%2FMD12052913

Cyclic ether-containing macrolactins, antimicrobial 24-membered isomeric macrolactones from a marine Bacillus sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMD12052913

Comparative study of the antimicrobial activity of bis(Nalpha-caproyl-L-arginine)-1,3-propanediamine dihydrochloride and chlorhexidine dihydrochloride against Staphylococcus aureus and Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMD12052913

Macrolactins O-R, glycosylated 24-membered lactones from Bacillus sp. AH159-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMD12052913

New macrolactins from a marine Bacillus sp. Sc026

21 January 2018

1 reference

12 December 2020

Thermotropic behavior of stratum corneum lipids containing a pseudo-ceramide

1 reference

12 December 2020

Where have all the antibiotic patents gone?

1 reference

12 December 2020

Macrolactin is the Polyketide Biosynthesis Product of the pks2 Cluster of Bacillus amyloliquefaciens FZB42

1 reference

12 December 2020

Marine natural products as sources of novel scaffolds: achievement and concern

1 reference

12 December 2020

Beneficial effects of pseudoceramide-containing physiologic lipid mixture as a vehicle for topical steroids

1 reference

12 December 2020

Novel macrolactins as antibiotic lactones from a marine bacterium

1 reference

12 December 2020

Identifiers

DOI

10.3390/MD12052913

1 reference

21 September 2017

1 reference

21 September 2017

1 reference